Clinical Professor of Medicine, University Miami School of Medicine
Oncology
Dr. Charles L. Vogel, MD
|
|
Give Review
Doctor Charles L. Vogel, MD is an expert in the field of Oncology. He attended Yale University School of Medicine. Yale University School of Medicine is a top medical college. Yale University School of Medicine has a rank of 7 in research and a 57 in primary care He received awards:"Regional Top Doctor", "CMS Meaningful Use Stage 1 Certification", "Super Doctor" and "Top MD". Charles Vogel is also published. He has 21 publications published. The lastest publication: "Progression-free survival as surrogate endpoint for overall survival in clinical trials of HER2-targeted agents in HER2-positive metastatic breast cancer.' He accepts Medicare payments and is listed with Medicare.gov.
Publications
- Progression-free survival as surrogate endpoint for overall survival in clinical trials of HER2-targeted agents in HER2-positive metastatic breast Cancer.
- A retrospective study evaluating a fixed low dose capecitabine monotherapy in women with HER-2 negative metastatic breast Cancer.
- Assessing the discordance rate between local and central HER2 testing in women with locally determined HER2-negative breast Cancer.
- Dual HER2-targeted approaches in HER2-positive breast Cancer.
- Phase II study of the antibody drug conjugate trastuzumab-DM1 for the treatment of human epidermal growth factor receptor 2 (HER2)-positive breast Cancer after prior H...
- High-dose estrogen as salvage hormonal therapy for highly refractory metastatic breast Cancer: a retrospective chart review.
- Pleomorphic lobular Carcinoma of the breast: four long-term responders to trastuzumab--coincidence or hint?
- Feasibility and cardiac safety of pegylated liposomal doxorubicin plus trastuzumab in heavily pretreated patients with recurrent HER2-overexpressing metastatic Breast ...
- Evaluation of clinical outcomes according to HER2 detection by fluorescence in situ hybridization in women with metastatic breast Cancer treated with trastuzumab.
- Trastuzumab plus chemotherapy: convincing survival benefit or not?
- Efficacy of trastuzumab.
- First and subsequent cycle use of pegfilgrastim prevents febrile neutropenia in patients with breast Cancer: a multicenter, double-blind, placebo-controlled phase III ...
- The role of the liposomal anthracyclines and other systemic therapies in the management of advanced breast Cancer.
- Randomized phase III trial of pegylated liposomal doxorubicin versus vinorelbine or mitomycin C plus vinblastine in women with taxane-refractory advanced breast Cancer.
- Safety and pain palliation of zoledronic acid in patients with breast Cancer, prostate Cancer, or multiple myeloma who previously received bisphosphonate therapy.
- Clinical experience with trastuzumab (herceptin).
- Trastuzumab and vinorelbine as first-line therapy for HER2-overexpressing metastatic breast cancer: multicenter phase II trial with clinical outcomes, Analysis of seru...
- Focused microwave phased array thermotherapy for primary breast Cancer.
- Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast Cancer.
- Pegylated liposomal doxorubicin (Doxil) for metastatic breast Cancer: the Cancer Research Network, Inc., experience.
Schools
Yale University School Of Medicine
Grady Meml Hospital
Med Br Dctnci
Procedures Preformed
- Cardiac MRI (Magnetic Resonance Imaging) of Heart or Chest
- Thoracentesis
Conditions Treated
- Acute Leukemia
- Anal and Rectal Cancer
- Anemia
- Basal Cell Carcinoma
- View All
Doctors Specialties
- Medical Oncology
- Oncology
Accepted Insurances
Awards
- Regional Top Doctor
- CMS Meaningful Use Stage 1 Certification
- Super Doctor
- Top MD
Education
-
Yale University School of Medicine
Hospital
-
University of Miami Hospital
Helpful Reviews
Similar Doctors
|
|
Dr. Jesus C. Fabregas Mercado, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Gotardo Rodrigues, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Michael B. Troner, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Mohammad Jahanzeb, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Lynn G. Feun, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Barry M. Kinzbrunner, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Frank I. Singleton Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Stefan Gluck, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jaime R. Merchan, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|